${loserAccounts} been merged into ${winnerAccount}.

A recent audit found these accounts to be duplicative. Addresses, order history and Q-global ordering for both accounts are now accessible via the ${winnerAccount} account. If something isn’t right, please contact us.

${loserAccounts} been merged into ${winnerAccount}.

A recent audit found these accounts to be duplicative. Addresses, qualified users, order history and Q-global ordering for both organizations are now accessible via the ${winnerAccount} account. If something isn’t right, contact us.

View all blogs

Pearson and Adaptive Testing Technologies to Offer Faster, More Accessible Mental and Behavioral Health Screenings for Adults and Teens

by

Adaptive Testing Technologies Logo

New agreement brings the CAT-MH® and K-CAT® assessments to Pearson's Q-global® clinical assessment platform later this year.

HOBOKEN – July 10, 2025 – Pearson (FTSE:PSON.L), the world’s lifelong learning company, and Adaptive Testing Technologies (ATT), a leader in unrivaled technology for measuring mental and behavioral health, today announced an agreement that will bring ATT’s computer adaptive testing (CAT) tools, known as the CAT-MH® and K-CAT®, to Pearson clinical customers worldwide.

The need is critical: The World Health Organization reports that over 280 million people worldwide are affected by depression, with millions more managing anxiety, PTSD, and other conditions. In the U.S. alone, the prevalence of depression in adolescents and adults has increased significantly over the past decade. This agreement directly addresses the rising need for timely and precise assessments.

Developed by ATT, the CAT-MH® (for adults) and K-CAT® (for children and adolescents) are computer adaptive assessments that measure symptom profiles across nine domains, including depression, anxiety, PTSD, and suicidality. Each assessment adapts in real time to patient responses, enabling clinicians to complete a comprehensive screening in under 10 minutes and deliver earlier, more accurate interventions.

Both suites of assessments will be integrated into Q-global, Pearson’s secure clinical assessment platform trusted by thousands of clinicians and educators for digital assessment administration, scoring, and reporting. The CAT-MH®, available in both English and Spanish, will launch on the Q-global platform later this year, followed by the K-CAT®.

“Pearson is pleased to be able to bring the CAT-MH® and K-CAT® into our Q-global platform of digital offerings,” said Scott Pawson, Sr. Business Strategist for Partnerships, Pearson Clinical Assessment. “Clinicians and educators will be able to use these remarkable tools to quickly triage client and student needs, assist in diagnostic decisions, and provide measurement-based care across treatment settings. These tools offer time- and cost-effective measurement of mental health concerns in both adults and adolescents."

“We are eager to work with Pearson and their Q-global platform, the world’s largest mental health evaluation platform, to extend the reach of our rigorously validated assessment tools. This strategic collaboration with Pearson represents a shared commitment to advancing clinical precision, improving early identification, and increasing access to gold-standard mental health assessments worldwide. Together, we aim to equip professionals with the data-driven insights they need to make timely, informed decisions that change lives,” said Hannah Wulczyn, Director at Adaptive Testing Technologies.